Wednesday, June 10

Browsing: EythrocyteantiPD1

Research

Eythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial

By NewsCancerFebruary 20, 20260

Couzin-Frankel, J. Breakthrough of the year 2013. Cancer immunotherapy. Science 342, 1432–1433 (2013).Article CAS PubMed Google Scholar Sharma, P., Hu-Lieskovan,…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Browsing: EythrocyteantiPD1

Eythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

Latest Post

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Subscribe to Updates

What's Hot

Browsing: EythrocyteantiPD1